ECHO Model for Advanced Cancer Care Quality
Trial Summary
What is the purpose of this trial?
This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live. Understanding the experiences and satisfaction of patients and caregivers may help improve healthcare workforce capacity and increase access to specialty care for the world's rural and underserved populations.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the research team or your doctor.
What data supports the effectiveness of the treatment Project ECHO for advanced cancer care?
How does the ECHO Model for Advanced Cancer Care Quality differ from other treatments for advanced cancer?
The ECHO Model is unique because it uses a telementoring approach to improve cancer care by connecting local healthcare providers with specialists, allowing for shared knowledge and best practices without the need for patients to travel. This model helps reduce disparities in cancer care, especially in underserved areas, by providing high-quality education and support to healthcare professionals.46789
Research Team
Sriram Yennu
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for adult patients with advanced cancer and their caregivers in Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia. Participants must be able to read English and have a life expectancy of at least one year. Caregivers need to be the primary support person. Healthcare providers interested in Project ECHO can also join if they commit for two years.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
ECHO Clinics and Workshops
Participants participate in online ECHO clinics over 1 hour twice monthly for 12 months and in-country workshops twice per year.
Patient and Caregiver Assessment
Patients and caregivers complete questionnaires and interviews about their experience and satisfaction with care.
Follow-up
Participants are monitored for changes in quality of life and symptom distress.
Treatment Details
Interventions
- Project ECHO (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Dr. Peter WT Pisters
M.D. Anderson Cancer Center
Chief Executive Officer since 2017
MD from University of Western Ontario
Dr. Jeffrey E. Lee
M.D. Anderson Cancer Center
Chief Medical Officer
MD from Stanford University School of Medicine
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School